# Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS

> **NCT05105685** · PHASE1,PHASE2 · COMPLETED · sponsor: **Affiliated Hospital of Jiangnan University** · enrollment: 6 (actual)

## Conditions studied

- Phelan-McDermid Syndrome
- Growth Hormone Treatment

## Interventions

- **DRUG:** recombinant human growth hormone
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05105685
- **Lead sponsor:** Affiliated Hospital of Jiangnan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-14
- **Primary completion:** 2021-05-12
- **Final completion:** 2021-06-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05105685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05105685, "Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05105685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*